Morning Briefing
Summaries of health policy coverage from major news organizations
Star-Ledger Examines Tibotec's Agreement With Generic Drug Makers On Experimental HIV/AIDS Treatment
In a piece on the move by drug manufacturer Tibotec Pharmaceuticals to grant licenses to generic manufacturers in India and South Africa to create copies of its experimental HIV/AIDS drug, the New Jersey Star-Ledger examines why drug companies are particularly focused on expanding their reach in sub-Saharan Africa.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
